A study in Canada looked at the effect of recreational cannabis legalization on alcohol sales across all provinces.
Researchers in Canada examined sales of alcohol compared with sales of recreational cannabis to gauge the effect of legalization in Canada in 2018 (1). The researchers noted that the data on cannabis being used in conjunction with alcohol or instead of alcohol is currently inconclusive (1). Previous US studies on this subject are not necessarily applicable to Canada for a variety of reasons, they also explained (1). Their study, “Association Between Non-Medical Cannabis Legalization and Alcohol Sales: Quasi-Experimental Evidence from Canada,” was published in Drug and Alcohol Dependence in February 2024 and is reportedly the first of its kind (1).
Using an Interrupted Time Series design, researchers examined monthly data on sale of spirits and of bottled, canned, and kegged beer sales before and after 2018 (1). Specifically, data on spirits sales from January 2016 to February 2020 along with beer sales from January 2012 to February 2020 was analyzed for each province (1). Cannabis use in the country increased from about 15% before legalization to nearly 17% in 2019 (1). Overall, they found that the legalization of cannabis was associated with a decline in some alcohol sales (1).
As listed in the study, highlights from the research include the following (1):
The results suggested that cannabis may be being used as a substitute for beer, researchers proposed (1). In the study’s discussion, researchers argued that though the decline in beer sales was modest, it was economically significant (1). Furthermore, the results could have implications for public health policies, particularly with preventing cannabis sales to minors (1). To overcome the limitations of this study, further studies could include long-term, post-pandemic data, more varied demographic groups, and the inclusion of other types of alcohol (1).
Related: see the effects of “Dry January” on cannabis sales compared to alcohol sales in the US.
Reference
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part II: Accreditation in the Cannabis Industry with Susan Audino
October 17th 2024In Part II of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, discuss the challenges in cannabis testing, the THC cap, and the need for better regulations.